14-3-3 Protein in CSF: An early predictor of SIV CNS disease

Journal of Neuropathology and Experimental Neurology

Volumn 64, Issue 3, 2005, Pages 202-208

  Helke, Kristi L ^a   Queen, Suzanne E ^a   Tarwater, Patrick M ^b   Turchan Cholewo, Jadwiga ^a   Nath, Avindra ^a   Zink, M Christine ^a   Irani, David N ^a   Mankowski, Joseph L ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

14 3 3 protein; CSF; HIV; Marker; Neurodegeneration; SIV

Indexed keywords

CD68 ANTIGEN; PROTEIN 14 3 3;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CULTURE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; DISEASE COURSE; ENCEPHALITIS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MACACA; MACROPHAGE; MICROGLIA; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; VIRUS LOAD; VIRUS REPLICATION;

EID: 15244341011     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/64.3.202     Document Type: Article

References (20)

1. Aitken A, Jones D, Soneji Y, Howell S. 14-3-3 proteins: Biological function and domain structure. Biochem Soc Trans 1995;23:605-11
2. Ferl RJ, Manak MS, Reyes MF. The 14-3-3s. Genome Biol 2002;3:1-7
3. Finnie C, Borch J, Collinge DB. 14-3-3 proteins: Eukaryotic regulatory proteins with many functions. Plant Mol Biol 1999;40:545-54
4. Berg D, Holzmann C, Riess O. 14-3-3 proteins in the nervous system. Nat Rev Neurosci 2003;4:752-62
5. Hsich G, Kenney K, Gibbs CJ, et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies. N Engl J Med 1996;335:924-30
6. Irani DN, Kerr DA. 14-3-3 protein in the cerebrospinal fluid of patients with acute transverse myelitis. Lancet 2000;355:901
7. Miller RF, Green AJ, Giovannoni G, et al. Detection of 14-3-3 brain protein in cerebrospinal fluid of HIV infected patients [Letter]. Sex Transm Infect 2000;76:408
8. Kenney K, Brechtel C, Takahashi H, et al. An enzyme-linked immunosorbent assay to quantify 14-3-3 proteins in the cerebrospinal fluid of suspected Creutzfeldt-Jakob disease patients. Ann Neurol 2000;48:395-98
9. Wakabayashi H, Yano M, Tachikawa N, et al. Increased concentrations of 14-3-3 epsilon, gamma and zeta isoforms in cerebrospinal fluid of AIDS patients with neuronal destruction. Clin Chim Acta 2001;312:97-105
10. Mankowski JL, Clements JE, Zink MC. Searching for clues: Tracking the pathogenesis of human immunodeficiency virus central nervous system disease by use of an accelerated, consistent simian immunodeficiency virus macaque model. J Infect Dis 2002;186(suppl 2):199-208
11. Zink MC, Amedee AM, Mankowski JL, et al. Pathogenesis of SIV encephalitis: Selection and replication of neurovirulent SIV. Am J Pathol 1997;151:793-803
12. Clements JE, Babas T, Mankowski JL, et al. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): Steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 2002;186:905-13
13. Zink MC, Suryanarayana K, Mankowski JL, et al. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol 1999;73:10480-88
14. Overholser ED, Coleman GD, Bennett JL, et al. Expression of simian immunodeficiency virus (SIV) nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro. J Virol 2003;77:6855-66
15. Turchan J, Pocernich CB, Gairola C, et al. Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 2003;60:307-14
16. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: A generalized estimating equation approach. Biometrics 1988;44:1049-60
17. Mankowski JL, Queen SE, Tarwater PM, et al. Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol 2002;61:85-90
18. Weed MR, Hienz RD, Brady JV, et al. Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection. J Neurovirol 2003;9:452-64
19. Bonora S, Zanusso G, Raiteri R, et al. Clearance of 14-3-3 protein from cerebrospinal fluid heralds the resolution of bacterial meningitis. Clin Infect Dis 2003;36:1492-95
20. Martinez-Yelamos A, Saiz A, Sanchez-Valle R, et al. 14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis. Neurology 2001;57:722-44